GIANCRISTOFARO, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 707
NA - Nord America 559
AS - Asia 357
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.626
Nazione #
US - Stati Uniti d'America 548
CN - Cina 156
IT - Italia 148
TR - Turchia 111
UA - Ucraina 97
IE - Irlanda 94
FR - Francia 91
SE - Svezia 85
IN - India 70
GB - Regno Unito 67
PL - Polonia 47
DE - Germania 34
FI - Finlandia 22
SG - Singapore 12
CA - Canada 11
RU - Federazione Russa 11
CZ - Repubblica Ceca 9
YE - Yemen 3
ES - Italia 2
KR - Corea 2
BR - Brasile 1
EU - Europa 1
ID - Indonesia 1
JO - Giordania 1
SA - Arabia Saudita 1
ZW - Zimbabwe 1
Totale 1.626
Città #
Jacksonville 108
Chandler 106
Dublin 94
Izmir 79
Dearborn 64
Southend 62
Kraków 47
Chieti 45
Nanjing 38
Cambridge 36
Princeton 35
Beijing 25
Nanchang 20
Ashburn 15
Jiaxing 13
Wilmington 13
Altamura 10
Ottawa 10
Brno 9
Houston 9
Teramo 9
Jinan 8
Kunming 8
Changsha 6
Hebei 6
Rome 6
Singapore 6
Tianjin 6
Boardman 5
Shenyang 5
Helsinki 4
Sulmona 4
Ann Arbor 3
Augusta 3
Fano 3
Guangzhou 3
Hangzhou 3
Hefei 3
Lanciano 3
Orange 3
Salerno 3
Sanaa 3
Vasto 3
Zhengzhou 3
Bari 2
Cagliari 2
Castel 2
Leawood 2
Moscow 2
Nürnberg 2
Orzivecchi 2
Pontassieve 2
Recanati 2
Siena 2
Valencia 2
Venafro 2
Washington 2
Anguillara Sabazia 1
Apo 1
Arezzo 1
Baltimore 1
Bellante 1
Bologna 1
Casarano 1
Changchun 1
Chicago 1
Düsseldorf 1
Fermo 1
Fuzhou 1
Grevenbroich 1
Guizhou 1
Harare 1
Kocaeli 1
Lanzhou 1
Mergo 1
Modugno 1
Napoli 1
Ningbo 1
Orsogna 1
Perugia 1
Pescara 1
Porto San Giorgio 1
Pozzo 1
Roseto Degli Abruzzi 1
San Mateo 1
Taiyuan 1
Toronto 1
Woodbridge 1
Yogyakarta 1
Totale 1.005
Nome #
null 128
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 123
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 116
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 111
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 102
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 101
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 101
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 100
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 99
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 95
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 90
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 90
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 83
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 79
Synthesis, biological evaluation and molecular modelling of new PPARa agonists 75
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 73
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 70
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 62
Synthesis, in vitro evaluation, and molecular modelling investigation of benzenesulfonimide Peroxisome Proliferator-Activated Receptors α antagonists 26
Totale 1.724
Categoria #
all - tutte 4.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020341 78 18 2 9 33 34 58 27 8 48 24 2
2020/2021125 22 2 22 0 9 21 2 1 26 15 0 5
2021/202292 2 0 0 32 6 0 0 5 16 3 10 18
2022/2023295 17 49 20 22 26 60 16 18 46 2 11 8
2023/2024124 9 3 11 1 6 32 39 0 2 1 3 17
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 1.724